Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients

British Journal of Haematology

Volumn 164, Issue 2, 2014, Pages 286-295

  Pallis, Flavia Rubia ^a   Conran, Nicola ^a   Fertrin, Kleber Yotsumoto ^a   Olalla Saad, Sara Terezinha ^a   Costa, Fernando Ferreira ^a   Franco Penteado, Carla Fernanda ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Chemokines; Eosinophils; Inflammation; Sickle cell anaemia

Indexed keywords

EOSINOPHIL PROTEIN X; EOTAXIN; HYDROXYUREA; PEROXIDASE; RANTES; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; CONTROLLED STUDY; DEGRANULATION; DISEASE ASSOCIATION; ENZYME RELEASE; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SICKLE CELL ANEMIA; YOUNG ADULT;

CHEMOKINES; EOSINOPHILS; INFLAMMATION; SICKLE CELL ANAEMIA;

ADOLESCENT; ADULT; AGED; ANEMIA, SICKLE CELL; ANTIGENS, CD; ANTISICKLING AGENTS; CASE-CONTROL STUDIES; CELL ADHESION; CELL ADHESION MOLECULES; CELL DEGRANULATION; CELL MEMBRANE; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; EOSINOPHILS; FEMALE; GPI-LINKED PROTEINS; HUMANS; HYDROXYUREA; INTEGRIN ALPHA4BETA1; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES; YOUNG ADULT;

EID: 84891631783     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12628     Document Type: Article

References (61)

1. Adamko, D.J., Wu, Y., Gleich, G.J., Lacy, P. & Moqbel, R. (2004) The induction of eosinophil peroxidase release: improved methods of measurement and stimulation. Journal of Immunological Methods, 291, 101-108.
2. Almeida, C.B., Favero, M.E., Pereira-Cunha, F.G., Lorand-Metze, I., Saad, S.T., Costa, F.F. & Conran, N. (2011) Alterations in cell maturity and serum survival factors may modulate neutrophil numbers in sickle cell disease. Experimental Biology and Medicine, 236, 1239-1246.
3. Amer, J., Ghoti, H., Rachmilewitz, E., Koren, A., Levin, C. & Fibach, E. (2006) Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. British Journal of Haematology, 132, 108-113.
4. Assis, A., Conran, N., Canalli, A.A., Lorand-Metze, I., Saad, S.T. & Costa, F.F. (2005) Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin. Acta Haematologica, 113, 130-136.
5. Blanchard, C. & Rothenberg, M.E. (2009) Biology of the eosinophil. Advances in Immunology, 101, 81-121.
6. Boyd, J.H., Macklin, E.A., Strunk, R.C. & De-Baun, M.R. (2006) Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood, 108, 2923-2927.
7. Bruijnzeel, P., Storz, E., van der Donk, E. & Bruijnzeel-Koomen, C. (1993) Skin eosinophilia in patients with allergic asthma, patients with nonallergic asthma, and healthy controls. II: 20-Hydroxy-leukotriene B4 is a potent in vivo and in vitro eosinophil chemotactic factor in nonallergic asthma. The Journal of Allergy and Clinical Immunology, 91, 634-642.
8. Canalli, A.A., Conran, N., Fattori, A., Saad, S.T. & Costa, F.F. (2004) Increased adhesive properties of eosinophils in sickle cell disease. Experimental Hematology, 32, 728-734.
9. Canalli, A.A., Franco-Penteado, C.F., Traina, F., Saad, S.T., Costa, F.F. & Conran, N. (2007) Role for cAMP-protein kinase A signalling in augmented neutrophil adhesion and chemotaxis in sickle cell disease. European Journal of Haematology, 79, 330-337.
10. Canalli, A.A., Proença, R.F., Franco-Penteado, C.F., Traina, F., Sakamoto, T.M., Saad, S.T., Conran, N. & Costa, F.F. (2011) Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatin. Haematologica, 96, 526-533.
11. Charache, S., Barton, F.B., Moore, R.D., Terrin, M.L., Steinberg, M.H., Dover, G.J., Ballas, S.K., McMahon, R.P., Castro, O. & Orringer, E.P. (1996) Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore), 75, 300-326.
12. Chiang, E.Y. & Frenette, P.S. (2005) Sickle cell vaso-occlusion. Hematology/Oncology Clinics of North America, 19, 771-784.
13. Chihara, J., Kakazu, T., Higashimoto, I., Yamamoto, T., Kurachi, D. & Nakajima, S. (1995) Increased eosinophil oxidative metabolism by treatment with soluble intercellular adhesion molecule-1. International Archives of Allergy and Immunology, 108, 45-47.
14. Chihara, J., Yamada, H., Yamamoto, T., Kurachi, D., Hayashi-Kameda, N., Honda, K., Kayaba, H. & Urayama, O. (1998) Priming effect of RANTES on eosinophil oxidative metabolism. Allergy, 53, 1178-1182.
15. Conran, N., Saad, S.T., Costa, F.F. & Ikuta, T. (2007) Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease. Annals of Hematology, 86, 255-261.
16. Costa, G.G., Silva, R.M., Franco-Penteado, C.F., Antunes, E. & Ferreira, H.H. (2007) Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils. European Journal of Pharmacology, 566, 200-205.
17. Dhalla, N.S., Temsah, R.M. & Netticadan, T. (2000) Role of oxidative stress in cardiovascular diseases. Journal of Hypertension, 18, 655-673.
18. Ekeke, G.I. (1987) Sickle cell disease: some haematological changes in steady state and crisis. Biomedica Biochimica Acta, 46, 197-201.
19. Elsner, J., Petering, H., Höchstetter, R., Kimmig, D., Wells, T.N., Kapp, A. & Proudfoot, A.E. (1997) The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3. European Journal of Immunology, 27, 2892-2898.
20. Elsner, J., Petering, H., Kimmig, D., Wells, T.N., Proudfoot, A.E. & Kapp, A. (1999) The CC chemokine receptor antagonist met- RANTES inhibits eosinophil effector functions. International Archives of Allergy and Immunology, 118, 462-465.
21. Elsner, J., Dulkys, Y., Gupta, S., Escher, S.E., Forssmann, W.G., Kapp, A. & Forssmann, U. (2005) Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3. Allergy, 60, 1386-1393.
22. Ferreira, H.H., Lodo, M.L., Martins, A.R., Kandratavicius, L., Salaroli, A.F., Conran, N., Antunes, E. & De Nucci, G. (2002) Expression of nitric oxide synthases and in vitro migration of eosinophils from allergic rhinitis subjects. European Journal of Pharmacology, 442, 155-162.
23. Field, J.J., Horst, J., Strunk, R.C., White, F.V. & DeBaun, M.R. (2011) Death due to asthma in two adolescents with sickle cell disease. Pediatric Blood & Cancer, 56, 454-457.
24. Gleich, G.J. & Adolphson, C.R. (1986) The eosinophilic leukocyte: structure and function. Advances in Immunology, 39, 177-253.
25. Hansel, T.T., De Vries, I.J., Iff, T., Rihs, S., Wandzilak, M., Betz, S., Blaser, K. & Walker, C. (1991) An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. Journal of Immunological Methods, 145, 105-110.
26. Hassan, H., Mughal, I., Dar, J., Al Mekki, T.E., Chapunduka, Z., Haddad, A. & Hassan, I.S. (2006) Significant bronchospasm during sickle cell painful crises is associated with a lower peripheral eosinophil count. Respirology, 11, 633-637.
27. Hofstra, T.C., Kalra, V.K., Meiselman, H.J. & Coates, T.D. (1996) Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst. Blood, 87, 4440-4447.
28. Holtzclaw, J.D., Jack, D., Aguayo, S.M., Eckman, J.R., Roman, J. & Hsu, L.L. (2004) Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice. American Journal of Respiratory and Critical Care Medicine, 169, 687-695.
29. Honda, K. & Chihara, J. (1999) Eosinophil activation by eotaxin primes the production of reactive oxygen species from eosinophils. Allergy, 54, 1262-1269.
30. Horie, S., Okubo, Y., Hossain, M., Sato, E., Nomura, H., Koyama, S., Suzuki, J., Isobe, M. & Sekiguchi, M. (1997) Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Internal Medicine, 36, 179-185.
31. Kim, K.W., Lee, K.E., Kim, E.S., Song, T.W., Sohn, M.H. & Kim, K.E. (2007) Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma. Lung, 185, 97-103.
32. Kinney, T.R., Helms, R.W., O'Branski, E.E., Ohene-Frempong, K., Wang, W., Daeschner, C., Vichinsky, E., Redding-Lallinger, R., Gee, B., Platt, O.S. & Ware, R.E. (1999) Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood, 94, 1550-1554.
33. Kita, H. (1996) The eosinophil: a cytokine producing cell? The Journal of Allergy and Clinical Immunology, 97, 889-892.
34. Klings, E.S. & Farber, H.W. (2001) Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respiratory Research, 2, 280-285.
35. Knight-Madden, J.M., Forrester, T.S., Lewis, N.A. & Greenough, A. (2005) Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax, 60, 206-210.
36. Kroegel, C., Yukawa, T., Dent, G., Venge, P., Chung, K.F. & Barnes, P.J. (1989) Stimulation of degranulation from human eosinophils by platelet-activating factor. The Journal of Immunology, 142, 3518-3526.
37. Kuijpers, T.W., Hoogerwerf, M., van der Laan, L.J., Nagel, G., van der Schoot, C.E., Grunert, F. & Roos, D. (1992) CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. The Journal of Cell Biology, 118, 457-466.
38. Lanaro, C., Franco-Penteado, C.F., Albuquerque, D.M., Saad, S.T., Conran, N. & Costa, F.F. (2009) Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. Journal of Leukocyte Biology, 85, 235-242.
39. Logan, M.R., Odemuyiwa, S.O. & Moqbel, R. (2003) Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. The Journal of Allergy and Clinical Immunology, 111, 923-932.
40. Mohamed, A.O., Hashim, M.S., Nilsson, U.R. & Venge, P. (1993) Increased in vivo activation of neutrophils and complement in sickle cell disease. American Journal of Tropical Medicine and Hygiene, 49, 799-803.
41. Morris, C.R. (2009) Asthma management: reinventing the wheel in sickle cell disease. American Journal of Hematology, 84, 234-241.
42. Morris, C.R. (2010) Role of arginase in sickle cell lung disease and hemolytic anemias. The Open Nitric Oxide Journal, 2, 41-54.
43. Moser, R., Fehr, J. & Bruijnzeel, P.L. (1992) IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. The Journal of Immunology, 149, 1432-1438.
44. Nagata, M., Sedgwick, J.B., Bates, M.E., Kita, H. & Busse, W.W. (1995) Eosinophil adhesion to vascular cell adhesion molecule activates superoxide anion generation. The Journal of Immunology, 155, 2194-2202.
45. Nandedkar, S.D., Feroah, T.R., Hutchins, W., Weihrauch, D., Konduri, K.S., Wang, J., Strunk, R.C., DeBaun, M.R., Hillery, C.A. & Pritchard, K.A. (2008) Histopathology of experimentally induced asthma in a murine model of sickle cell disease. Blood, 112, 2529-2538.
46. Newaskar, M., Hardy, K.A. & Morris, C.R. (2011) Asthma in sickle cell disease. Scientific World Journal, 26, 1138-1152.
47. Nordness, M.E., Lynn, J., Zacharisen, M.C., Scott, P.J. & Kelly, K.J. (2005) Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clininical and Molecular Allergy: CMA, 3, 2.
48. Oh, S.O., Ibe, B.O., Johnson, C., Kurantsin-Mills, J. & Raj, J.U. (1997) Platelet-activating factor in plasma of patients with sickle cell disease in steady state. Journal of Laboratory and Clinical Medicine, 130, 191-196.
49. Phillips, R.M., Stubbs, V.E., Henson, M.R., Williams, T.J., Pease, J.E. & Sabroe, I. (2003) Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter. The Journal of Immunology, 170, 6190-6201.
50. Ponath, P.D., Qin, S., Ringler, D.J., Clark-Lewis, I., Wang, J., Kassam, N., Smith, H., Shi, X., Gonzalo, J.A., Newman, W., Gutierrez-Ramos, J.C. & Mackay, C.R. (1996) Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. Journal of Clinical Investigation, 97, 604-612.
51. Rothenberg, M.E. & Hogan, S.P. (2005) The Eosinophil. Annual Review of Immunology, 24, 147-174.
52. Saleh, A.W., Hillen, H.F. & Duits, A.J. (1999) Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy. Acta Haematologica, 102, 31-37.
53. Sehmi, R., Wardlaw, A.J., Cromwell, O., Kurihara, K., Waltmann, P. & Kay, A.B. (1992) Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood, 79, 2952-2959.
54. Steinberg, M.H., Lu, Z.H., Barton, F.B., Terrin, M.L., Charache, S. & Dover, G.J. (1997) Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood, 89, 1078-1088.
55. Stocks, S.C., Ruchaud-Sparagano, M.H., Kerr, M.A., Grunert, F., Haslett, C. & Dransfield, I. (1996) CD66: role in the regulation of neutrophil effector function. European Journal of Immunology, 26, 2924-2932.
56. Sylvester, K.P., Patey, R.A., Broughton, S., Rafferty, G.F., Rees, D., Thein, S.L. & Greenough, A. (2007) Temporal relationship of asthma to acute chest syndrome in sickle cell disease. Pediatric Pulmonology, 42, 103-106.
57. Walter, P.B., Fung, E.B., Killilea, D.W., Jiang, Q., Hudes, M., Madden, J., Porter, J., Evans, P., Vichinsky, E. & Harmatz, P. (2006) Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. British Journal of Haematology, 135, 254-263.
58. Warringa, R.A., Schweizer, R.C., Maikoe, T., Kuijper, P.H., Bruijnzeel, P.L. & Koendermann, L. (1992) Modulation of eosinophil chemotaxis by interleukin-5. American Journal of Respiratory and Cell Molecular Biology, 7, 631-636.
59. Williams, T.J. & Jose, P.J. (2000) Role of eotaxin and related CC chemokines in allergy and asthma. Chemical Immunology, 78, 166-177.
60. Yoon, J., Terada, A. & Kita, H. (2007) CD66b regulates adhesion and activation of human eosinophils. The Journal of Immunology, 179, 8454-8462.
61. Zimmermann, N., King, N.E., Laporte, J., Yang, M., Mishra, A., Pope, S.M., Muntel, E.E., Witte, D.P., Pegg, A.A., Foster, P.S., Hamid, Q. & Rothenberg, ME. (2003) Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. Journal of Clinical Investigation, 111, 1863-1874.